REPONEX PHARMACEUTICALS A/S
CVR number: 30082346
Slotsmarken 18, 2970 Hørsholm
www.reponex.dk
Income statement (kDKK)
2016 | |
---|---|
Fiscal period length | 12 |
Net sales | |
Gross profit | 241.00 |
Costs of management | - 506.00 |
Costs of distribution | -37.00 |
EBIT | - 302.00 |
Other financial expenses | - 118.00 |
Pre-tax profit | - 420.00 |
Income taxes | 88.00 |
Net earnings | - 332.00 |
Assets (kDKK)
2016 | |
---|---|
Development expenditure | 1 335.00 |
Intangible rights | 2 657.00 |
Intangible assets total | 3 992.00 |
Tangible assets total | |
Investments total | |
Long term receivables total | |
Raw materials and consumables | 487.00 |
Inventories total | 487.00 |
Prepayments and accrued income | 158.00 |
Current other receivables | 154.00 |
Current deferred tax assets | 493.00 |
Short term receivables total | 805.00 |
Cash and bank deposits | 2 658.00 |
Cash and cash equivalents | 2 658.00 |
Balance sheet total (assets) | 7 942.00 |
Equity and liabilities (kDKK)
2016 | |
---|---|
Share capital | 133.00 |
Share premium account | 6 940.00 |
Other reserves | 1 668.00 |
Retained earnings | -3 180.00 |
Profit of the financial year | - 332.00 |
Shareholders equity total | 5 229.00 |
Provisions | 655.00 |
Non-current other liabilities | 1 671.00 |
Non-current liabilities total | 1 671.00 |
Current trade creditors | 319.00 |
Other non-interest bearing current liabilities | 68.00 |
Current liabilities total | 387.00 |
Balance sheet total (liabilities) | 7 942.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.